226 related articles for article (PubMed ID: 19036222)
1. Bone and maxillofacial abnormalities in thalassemia: a review of the literature.
Di Matteo R; Liuzza F; Manicone PF; Raffaelli L; Berardi D; Perfetti G; Maccauro G
J Biol Regul Homeost Agents; 2008; 22(4):211-6. PubMed ID: 19036222
[TBL] [Abstract][Full Text] [Related]
2. Subtrochanteric femoral fracture in a 26 year old woman affected by beta-thalassemia major due to minor trauma: analysis of bone modification causing the complication.
Di Matteo R; Liuzza F; Pezzillo F; Gerardino L; Maccauro G
Clin Ter; 2007; 158(5):425-9. PubMed ID: 18062349
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism analysis in the COLIA1 gene of patients with thalassemia major and intermedia.
Arisal O; Deviren A; Fenerci EY; Hacihanefioglu S; Ulutin T; Erkmen S; Buyru N
Haematologia (Budap); 2002; 32(4):475-82. PubMed ID: 12803121
[TBL] [Abstract][Full Text] [Related]
4. Survival and complications in thalassemia.
Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in the prevalence and severity of bone disease in thalassaemia.
Kyriakou A; Savva SC; Savvides I; Pangalou E; Ioannou YS; Christou S; Skordis N
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():116-22. PubMed ID: 19337164
[TBL] [Abstract][Full Text] [Related]
6. The pattern of bone disease in transfusion-dependent thalassemia major patients.
Katz K; Horev G; Goshen J; Tamary H
Isr J Med Sci; 1994 Aug; 30(8):577-80. PubMed ID: 8045734
[TBL] [Abstract][Full Text] [Related]
7. Use of hormone replacement therapy for correction of high turnover bone disease in hypogonadal β-Thalassemia major patients presenting with osteoporosis: comparison with idiopathic premature ovarian failure.
Chatterjee R; Katz M; Bajoria R
Hemoglobin; 2011; 35(5-6):653-8. PubMed ID: 22074125
[TBL] [Abstract][Full Text] [Related]
8. Malignancies in β-thalassemia patients: first description of two cases of thyroid cancer and review of the literature.
Poggi M; Sorrentino F; Pascucci C; Monti S; Lauri C; Bisogni V; Toscano V; Cianciulli P
Hemoglobin; 2011; 35(4):439-46. PubMed ID: 21797713
[TBL] [Abstract][Full Text] [Related]
9. Alpha and beta thalassemia.
Muncie HL; Campbell J
Am Fam Physician; 2009 Aug; 80(4):339-44. PubMed ID: 19678601
[TBL] [Abstract][Full Text] [Related]
10. Effects of teriparatide retreatment in a patient with β-thalassemia major.
Tournis S; Dede AD; Savvidis C; Triantafyllopoulos IK; Kattamis A; Papaioannou N
Transfusion; 2015 Dec; 55(12):2905-10. PubMed ID: 26174236
[TBL] [Abstract][Full Text] [Related]
11. Effect of bisphosphonate treatment on bone mineral density in patients with thalassaemia major.
Skordis N; Ioannou YS; Kyriakou A; Savva SC; Efstathiou E; Savvides I; Christou S
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():144-8. PubMed ID: 19337169
[TBL] [Abstract][Full Text] [Related]
12. Endocrine complications in patients with Thalassaemia Major.
Toumba M; Sergis A; Kanaris C; Skordis N
Pediatr Endocrinol Rev; 2007 Dec; 5(2):642-8. PubMed ID: 18084158
[TBL] [Abstract][Full Text] [Related]
13. Thalassemias and their dental implications.
Cutando Soriano A; Gil Montoya JA; López-González Garrido Jde D
Med Oral; 2002; 7(1):36-40, 41-5. PubMed ID: 11788807
[TBL] [Abstract][Full Text] [Related]
14. Bone disease in β thalassemia patients: past, present and future perspectives.
De Sanctis V; Soliman AT; Elsefdy H; Soliman N; Bedair E; Fiscina B; Kattamis C
Metabolism; 2018 Mar; 80():66-79. PubMed ID: 28987275
[TBL] [Abstract][Full Text] [Related]
15. Vertebral collapse in thalassemia intermedia: case report.
Mangiagli A; Campisi S; Marsella M; De Sanctis V
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():136-9. PubMed ID: 19337167
[TBL] [Abstract][Full Text] [Related]
16. Pathogenetic aspects of immune deficiency associated with beta-thalassemia.
Farmakis D; Giakoumis A; Polymeropoulos E; Aessopos A
Med Sci Monit; 2003 Jan; 9(1):RA19-22. PubMed ID: 12552254
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histological modifications in osteopetrotic bone: a review.
Scaramuzzo L; Messuti L; Manicone PF; Raffaelli L; Rossi B; Gallenzi P; Berardi D; Maccauro G
J Biol Regul Homeost Agents; 2009; 23(2):59-63. PubMed ID: 19589285
[TBL] [Abstract][Full Text] [Related]
18. Osteoprotegerin and RANKL in the pathogenesis of osteoporosis in patients with thalassaemia major.
Pietrapertosa AC; Minenna G; Colella SM; Santeramo TM; Renni R; D'Amore M
Panminerva Med; 2009 Mar; 51(1):17-23. PubMed ID: 19352306
[TBL] [Abstract][Full Text] [Related]
19. Endocrine and bone complications in β-thalassemia intermedia: current understanding and treatment.
Inati A; Noureldine MA; Mansour A; Abbas HA
Biomed Res Int; 2015; 2015():813098. PubMed ID: 25834825
[TBL] [Abstract][Full Text] [Related]
20. Congestive heart failure and treatment in thalassemia major.
Aessopos A; Kati M; Tsironi M
Hemoglobin; 2008; 32(1-2):63-73. PubMed ID: 18274984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
